Tower Research Capital LLC (TRC) - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 26 filers reported holding CANCER GENETICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q3 2017$4,000
-76.5%
1,342
-68.9%
0.00%
-100.0%
Q2 2017$17,000
+750.0%
4,317
+560.1%
0.00%
Q1 2016$2,000
+100.0%
654
+227.0%
0.00%
Q4 2015$1,000
-66.7%
200
-40.7%
0.00%
Q3 2015$3,000
+50.0%
337
+22.1%
0.00%
Q1 2015$2,000
-91.7%
276
-89.6%
0.00%
-100.0%
Q3 2014$24,000
+166.7%
2,661
+216.8%
0.00%
+200.0%
Q2 2014$9,000
+50.0%
840
+100.0%
0.00%0.0%
Q1 2014$6,000
-45.5%
420
-47.5%
0.00%
-50.0%
Q4 2013$11,0008000.00%
Other shareholders
CANCER GENETICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
DOMINI IMPACT INVESTMENTS LLC 23,937$187,0003.26%
Millrace Asset Group, Inc. 166,083$1,297,0001.43%
Sterneck Capital Management, LLC 56,950$445,0000.24%
GRUBER & MCBAINE CAPITAL MANAGEMENT LLC 83,900$655,0000.18%
Quality Growth Management, Inc. 23,500$184,0000.15%
TURNER INVESTMENTS LLC 99,930$781,0000.14%
ARDSLEY ADVISORY PARTNERS LP 70,700$552,0000.08%
Granite Investment Partners, LLC 110,511$863,0000.07%
DIKER MANAGEMENT LLC 23,015$180,0000.03%
Stevens First Principles Investment Advisors 1,000$8,0000.01%
View complete list of CANCER GENETICS INC shareholders